Finance

Beta
Lists
1HM:FRA
Adaptive Biotechnologies Corp
€14.57
+5.66%
(+0.78) 1D
Jun 17, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1HM...
Open
€14.57
High
€14.57
Low
€14.57
Mkt. cap
2.69B
Avg. vol.
151.00
Volume
0.00
52-wk high
€17.70
52-wk low
€8.69
No. of employees
624
Open
€14.57
High
€14.57
Low
€14.57
Mkt. cap
2.69B
Avg. vol.
151.00
Volume
0.00
52-wk high
€17.70
52-wk low
€8.69
No. of employees
624
News stories
From sources across the web
About Adaptive Biotechnologies Corp
CEOChad Robins
Employees624
Founded2009
HeadquartersSeattle, Washington, United States
SectorHealth care
Websiteadaptivebiotech.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
58.88M
93.97M
71.68M
70.87M
Cost of goods sold
42.13M
41.83M
39.99M
42.33M
Cost of revenue
42.13M
41.83M
39.99M
42.33M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.36M
41.43M
44.04M
47.33M
Operating expense
41.78M
41.86M
44.47M
47.75M
Total operating expenses
83.92M
83.68M
84.45M
90.08M
Operating income
-25.04M
10.29M
-12.77M
-19.21M
Other non operating income
-
-
-
-
EBT including unusual items
-25.59M
9.54M
-13.58M
-20.02M
EBT excluding unusual items
-25.59M
9.54M
-13.87M
-20.15M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-25.61M
9.55M
-13.58M
-20.03M
Net profit margin
-43.50%
10.16%
-18.94%
-28.27%
Earnings per share
-0.17
0.06
-0.09
-0.13
Interest and investment income
2.39M
2.23M
1.86M
1.94M
Interest expense
-2.95M
-2.97M
-2.95M
-2.89M
Net interest expenses
-557.00K
-745.00K
-1.09M
-945.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.53M
14.70M
-8.58M
-15.37M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer